Concepedia

Mary L. Morris

ML

Statistics

Publications

10

Citations

1K

H-Index

10

Active since

1957

Affiliations

Ottawa Hospital(Current)

University of Ottawa

Wellesley College

Massachusetts General Hospital

Harvard University

Mary L. Morris is an author at Ottawa Hospital specializing in vaccine immunology, immunology, and vaccination.

Publications per year

1957–2006

10

Publications

10

CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

Curtis Cooper, Heather L. Davis, Mary L. Morris et al. · Journal of Clinical Immunology · 2004 · 330 citations

, , +17

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

Curtis Cooper, Heather L. Davis, Mary L. Morris et al. · Vaccine · 2004 · 245 citations

, , +14

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults

Curtis Cooper, Heather L. Davis, Jonathan B. Angel et al. · AIDS · 2005 · 191 citations

, , +17

Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response

Claire‐Anne Siegrist, Maria Pihlgren, Chantal Tougne et al. · Vaccine · 2004 · 107 citations

, , +15

Deiodination of Diiodotyrosine by Cell-Free Systems

John B. Stanbury, Mary L. Morris · Journal of Biological Chemistry · 1958 · 72 citations · Full text

, , +3

1–5 of 10